The Discovery and Development of Liraglutide and Semaglutide
The discovery of glucagon-like peptide-1 (GLP-1), an incretin hormone with important effects on glycemic control and body weight regulation, led to efforts to extend its half-life and make it therapeutically effective in people with type 2 diabetes (T2D). The development of short- and then long-acti...
Saved in:
Published in | Frontiers in endocrinology (Lausanne) Vol. 10; p. 155 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
12.04.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!